Summary
Due to improved sanitation and prevention of parenterally transmitted diseases, a trend towards a decreasing incidence of acute viral hepatitis has been observed in several countries in the last years. These changes in epidemiology affect elderly people in different ways, especially if they are residents of homes for the aged. The decrease of hepatitis A virus (HAV) infection in childhood has resulted in less antibody protection during adulthood and old age. This in turn has led to an increased risk of acute and severe hepatitis due to HAV infection, and/or community outbreaks even in elderly people.
The spread of parenterally transmitted viruses, such as hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis delta virus (HDV), occurs in homes for the aged, mainly through the common use of toiletries and nondisposable syringes. Improvement in hygiene standards has lead to a marked decrease of these infections.
In conclusion, provided that the current hygiene standards are maintained, the risk of parenterally transmitted hepatitis viruses (HBV, HCV and HDV) in homes for the aged will be low. Paradoxically, the risk of enterically transmitted HAV may, in the near future, increase in wealthy institutions and/or in Western countries.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Krugman S, Giles JP. Viral hepatitis: new light in an old disease. JAMA 1970; 212: 1019–29
Richer G, Desrochers M, Guevin R, et al. Hepatitis B antigen in Montreal blood donors: childhood institutionalization as an epidemiological factor. Can Med Assoc J 1975; 112: 49–52
Szmuness W, Pick R, Prince AM. The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded. Am J Epidemiol 1970; 95: 51–61
Szmuness W, Prince AM. The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions. Am J Epidemiol 1971; 94: 585–95
Szmuness W, Prince AM, Etling GF, et al. Development and distribution of haemoagglutinating antibody against the hepatitis B antigen in institutionalized populations. J Infect Dis 1972; 126: 498–506
Tevaluoto-Aarnio M. Epidemiology of hepatitis B antigenemia in an institution for the mentally retarded. Scand J Infect Dis 1974; 6: 309–13
Tevaluoto-Aarnio M, Werner B, London WT. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded. Med Biol 1975; 53: 51–9
Perry E, Chaudhary RK, Cleary TE, et al. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded. Can Med Assoc J 1975; 112: 46–8
Nordenfelt E, Andren-Sandberg M, Lundquist A, et al. Persistence of Australia (Au) antigen among patients in a hospital for the mentally retarded and its relation to chronic liver disease. Scand J Infect Dis 1971; 3: 103–7
Boughton CR, Hawkes RA, Schroeter DR, et al. The epidemiology of hepatitis B in a residential institution for mentally retarded. Aust N Z J Med 1976; 6: 521–4
Kingham JGC, McGuire M, Paine DHD, et al. Hepatitis B in a hospital for the mentally subnormal in southern England. BMJ 1978; 2: 594–6
Fitzerald GR, Grimes H, Reynolds M, et al. Hepatitis-associated-antigen positive hepatitis in a tuberculosis unit. Gut 1975; 16: 1543–5
Szmuness W, Dienstag JL, Purcell RH, et al. The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol 1977; 106: 392–8
Majeed FA, Stuart JM, Cartwright KAV, et al. An outbreak of hepatitis A in Gloucester, UK. Epidemiol Infect 1992; 109: 167–73
Vendramini R, Fiaschi E, Naccarato R, et al. Epatitie virale tipi A: indagine sieroepidemiologica in Padova e provincia. Boll Ist Sieroter Milan 1980; 59: 338–47
Turner PC, Eglin RE, Woodward CG, et al. Screening before hepatitis A vaccination. Lancet 1992; 340: 1160
Finkelstein MA, Freedman ML, Shenkman L, et al. Evidence of prior hepatitis B and hepatitis A virus infections in an ambulatory geriatric population. J Gerontology 1981; 36: 302–5
Kremastinou J, Kalapothaki V, Trichopoulos D. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 1984; 120: 703–6
Hsu HJ, Chang MH, Chen DS, et al. Changing seroepidemiology of hepatitis A infection in Taiwan. J Med Virol 1985; 17: 297–301
Chiaramonte M, Moschen ME, Stroffolini T, et al. Changing epidemiology of hepatitis A virus (HAV) infection: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy. Ital J Gastroenterol 1991; 23: 344–6
Papaevangelou V, Roumelioto-Karayannis A, Contoyannis P. Changing epidemiological characteristics of acute viral hepatitis in Greece. Infection 1982; 10: 1–4
Dubois F, Thevenas C, Caces E, et al. Seroepidemiologie de l’hepatite A dans six departements du Centre-Ouest de la France en 1991. Gastroenterol Clin Biol 1992; 16: 674–9
Stroffolini T, Biagini W, Lorenzoni L, et al. An outbreak of hepatitis A in young adults in central Italy. Eur J Epidemiol 1990; 6: 156–9
Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10Suppl. 1: S63–S66
Fenstel LF. Viral hepatitis in the elderly. Gastroenterology 1965; 49: 262–71
Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453–7
Siegl G, Lemon SM. Recent advances in hepatitis A vaccine development. Virus Res 1990; 17: 75–92
Scheifele DW, Bjornson GJ. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. Can Med Assoc J 1993; 148: 551–5
Niu MT, Polish LB, Robertson BH, et al. Multistate outbreak of Hepatitis A associated with frozen strawberries. J Infect Dis 1992; 166: 518–24
Szmuness W, Harley EJ, Prince AM. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci 1975; 270: 293–6
Bruguera M, Bosh J, Rodes J, et al. Familial clustering of hepatitis B antigen: a study in relatives of patients with liver diseases and hepatitis B antigenaemia. BMJ 1974; 2: 495–6
Braconier JH, Nordenfelt E. Serum hepatitis at a home for the aged. Scand J Infect Dis 1972; 4: 79–82
Wright RA. Hepatitis B and the HBsAg carrier: an outbreak related to sexual contact. JAMA 1975; 232: 717–21
Chiaramonte M, Floreani A, Naccarato R. Hepatitis B virus infection in homes for the aged. J Med Virol 1982; 9: 247–55
Floreani A, Bertin T, Soffiati G, et al. Are homes for the elderly still a risk area for HBV infection? Eur J Epidemiol 1992; 8: 808–11
Trivello R, Chiaramonte M, Naccarato R, et al. Epatite virale B: indagine sieroepidemiologica nel Veneto. Boll Ist Sieroter Milan 1982; 61: 136–43
Papaevangelou GJ, Roumeliotou A. Reduction of HBV infections and mass immunization. Lancet 1988; 2: 53–4
Matsuo A, Kusumoto Y, Ohtsuka E, et al. Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan. Lancet 1990; 1: 955–7
Mele A, Stazi MA, Corona RM, et al. Decline of incidence of A, B and non-A, non-B hepatitis in Italy: results of four years surveillance (1985–88). Ital J Gastroenterol 1990; 22: 274–80
Chiaramonte M, Trivello R, Stroffolini T. Changing pattern of hepatitis B infection in children: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy. Ital J Gastroenterol 1991; 23: 347–50
Kane MA. Progress on the control of hepatitis B infection through immunization. Gut 1993; 34 (Suppl.): S10–S12
Snydman DR, Hindman SH, Wineland MD, et al. Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients. Ann Int Med 1976; 86: 573–6
Pattison CP, Maynard JE, Berquist KR, et al. Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol 1975; 101: 59–62
Denis F, Mounier M, Hessel L, et al. Hepatitis-B vaccination in the elderly. J Infect Dis 1984; 149: 1019–21
Chiaramonte M, Floreani A, Naccarato R. Hepatitis B virus (HBV) in the elderly: an underestimated problem? Biomed Pharmacother 1987; 41: 121–3
Wong DKH, Cheung AM, O’Rourke K, et al. Effect of alpha interferon treatment in patients with hepatitis B and antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993; 119: 312–23
Chiaramonte M, Floreani A, Delaito M, et al. Predictive factors of major side effects during Interferon (IFN) therapy [abstract]. Hepatology 1994. In press
Sherlock S. Strategies for treating chronic hepatitis B and chronic hepatitis C infections. L’inernista 1993; 3: 139–43
Lam KC, Lai CL, Ng PR, et al. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981; 304: 380–6
Centers for Disease Control: MMWR. Update: universal precautions for preventions of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in healthcare settings. MMWR Morb Mort Week Rep 1988; 37: 377–88
Rizzetto M. The delta agent. Hepatology 1983; 3: 729–37
Sagnelli E, Stroffolini T, Ascione A, et al. Epidemiology of hepatitis delta infection in Italy. J Hepatol 1992; 15: 211–5
Chiaramonte M, Stroffolini T, Caporaso N, et al. Hepatitis C virus infection in Italy: a multicentric serepidemiological study. Ital J Gastroenterol 1991; 255–8
Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4
Chang T-T, Liou T-C, Young K-C, et al. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994; 42: 91–6
Reesink HW, Wong VCW, Ip HMH, et al. Mother-to-infant transmission and hepatitis C virus. Lancet 1990; 335: 1216–7
Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. New Engl J Med 1994; 330: 744–50
Melbye M, Biggar R, Wantzin P, et al. Sexual transmission of hepatitis C virus: cohort study (1981–89) among European homosexual men. BMJ 1990; 301: 210–2
Tedder RS, Gilson RJ, Briggs M, et al. Hepatitis C virus: evidence for sexual transmission. BMJ 1991; 302: 1299–1302
Pachucki CT, Lentino JR, Schaaff D, et al. Low prevalence of sexual transmission of hepatitis C virus in sex partners of seropositive intravenous drug users. J Infect Dis 1991; 164: 820–1
Goodson JD, Taylor PA, Campion EW, et al. The clinical course of acute hepatitis in the elderly patients. Arch Intern Med 1982; 142: 1485–2
Sonnenblick M, Oren R, Tur-Kaspa R. Non A, non B hepatitis in the aged. Postgrad Med J 1990; 66: 462–4
Sirchia G, Almini D, Bellobuono A, et al. Prevalence of hepatitis C virus antibodies in Italian blood donors: the Italian Cooperative Group. Vox Sang 1990; 59: 26–9
Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2; 294–7
Watanabe J, Minegishi K, Mitsumori T, et al. Prevalence of anti-HCV antibody in blood donors in Tokyo area. Vox Sang 1990; 59: 86–8
Archer GT, Buring ML, Clark B, et al. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992; 157: 225–7
Simor AE, Gordon M, Bishai FR. Prevalence of hepatitis B surface antigen, hepatitis C antibody, and HIV-1 antibody among residents of a long-term-care facility. J Am Geriatr Soc 1992; 40: 218–20
Floreani A, Bertin T, Soffiati G, et al. Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. Gerontology 1992: 38: 214–6
Rapicetta M, Attili AF, Mele A, et al. Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population. J Med Virol 1992; 37: 87–92
Tiné F, Magrin S, Craxi A, et al. Interferon for non-A, non-B chronic hepatitis: a meta-analysis of randomised clinical trials. J Hepatol 1991; 13: 192–9
Lindsay KL. Chronic hepatitis C: issues and problems with current therapy. Postgraduate course of the American Association for the Study of Liver Diseases, November 4–5, 1993, Chicago, Illinois: 131–50
Alter HJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231–5
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Floreani, A., Chiaramonte, M. Hepatitis in Nursing Homes. Drugs & Aging 5, 96–101 (1994). https://doi.org/10.2165/00002512-199405020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199405020-00003